All filters
Slidesets
Steps count is associated with adverse health outcomes in HIV patients better than traditional HIV variables- Giovanni Guaraldi, MD
Presented at:
International Workshop on HIV & Aging 2017
Slidesets
Current reality: The San Francisco experience- Meredith Greene, MD
Presented at:
International Workshop on HIV & Aging 2017
Slidesets
OMICS in the context of aging and Alzheimer's disease- Madhav Thambisetty, MD
Presented at:
International Workshop on HIV & Aging 2017
Slidesets
The researcher perspective- Phyllis Tien, MD
Presented at:
International Workshop on HIV & Aging 2017
Slidesets
Current reality: The New York experience- Eugenia Siegler, MD
Presented at:
International Workshop on HIV & Aging 2017
Slidesets
The NIH perspective- Maureen Goodenow, PhD
Presented at:
International Workshop on HIV & Aging 2017
Slidesets
Clinical Case Discussion 1- Dr. T.R. Constant Vergara
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Is Baseline Resistance Testing Needed?- Ricardo Diaz, MD
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Clinical Case Discussion 3- Dr. M.C.Rachid de Lacerda
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
The Role of HIV Integrase Inhibitors in PrEP & PEP- Richard Elion
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
HIV Integrase Inhibitors in an Aging Population (Polypharmacy - Comorbidities)- Dr. M.C.Rachid de Lacerda
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Clinical Case on Integrase Inhibitors Use in TB-Infected Patients- Dr. L. Grinsztejn
Presented at:
Brazilian HIV Clinical Forum 2017
Meeting
Global HIV Clinical Forum 2017
Slidesets
Basic Science of Integrase Inhibitors - Recent Advances- Francois Clavel, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Potential role of Integrase Inhibitors in resource-limited settings- Gary Maartens, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Resistance Characteristics of Integrase Inhibitors- Charlotte Charpentier, PharmD, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical Pharmacology related considerations- David Back, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Pediatric use of Integrase Inhibitors- Mark Cotton, MD, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Optimal Use of Integrase Inhibitors in Women- Sharon Walmsley, FRCPC, MD, MSC
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Mutations to Integrase inhibitors in real life- Dr. Isabel Viciana Ramos
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical case of transmitted resistance to HIV Integrase Inhibitors- Dr. Carmen María González Domenech
Presented at:
Global HIV Clinical Forum 2017
Slidesets
The Role of Integrase Inhibitors during HIV prevention- Pep Coll, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical Case -Reduced Drug Regimen- Pedro Cahn, MD, PhD
Presented at:
Global HIV Clinical Forum 2017